SCHEMBL16124500

SCHEMBL16124500

COC(=O)CCc1cc(I)c(Oc2ccc(OC)c(C(=O)Nc3ccccc3)c2)c(I)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.46
▸ NR1H4 Q96RI1 1/20 0.45
▸ PCNA P12004 3/20 0.45
▸ POLB P06746 2/20 0.45
▸ THRA P10827 2/20 0.45
▸ THRB P10828 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ KMT2A Q03164 5/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ LRRK2 Q5S007 1/20 0.43
▸ AHR P35869 2/20 0.43
▸ KCNK3 O14649 2/20 0.43
▸ KCNK9 Q9NPC2 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14485284 0.87 HPGD (0.51) PCNAPOLBTHRATHRBMAPK1
SCHEMBL14484723 0.87 PCNA (0.51) SMN1; SMN2KDM4EPCNAPOLBTHRA
SCHEMBL16124502 0.80 THRB (0.66) SMN1; SMN2PCNAPOLBTHRATHRB
SCHEMBL14484785 0.77 PCNA (0.48) SMN1; SMN2HTTKDM4EPCNAPOLB
SCHEMBL14485257 0.77 PCNA (0.61) HTTPCNAPOLBTHRATHRB
SCHEMBL16124445 0.76 PCNA (0.56) SMN1; SMN2PCNAPOLBTHRATHRB
SCHEMBL16124464 0.76 PCNA (0.53) SMN1; SMN2PCNAPOLBTHRATHRB
SCHEMBL16124417 0.75 PCNA (0.63) SMN1; SMN2PCNAPOLBTHRATHRB
SCHEMBL12642750 0.74 PCNA (0.74) PCNAPOLBTHRATHRBMAPK1
SCHEMBL2060592 0.72 NR1H4 (0.57) SMN1; SMN2HTTNR1H4POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF SMN1; SMN2 4848/4885HTT 1913/4885KDM4E 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback